Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
Document › Details

Danaher Corporation. (7/1/15). "Press Release: Danaher Announces Pricing of Euro-Denominated Senior Notes Offering". Washington, DC.

Region Region London, Greater London
  Country United Kingdom (GB)
Organisations Organisation Danaher Corporation (NYSE: DHR)
  Group Danaher (Group)
  Organisation 2 Pall Corporation (NYSE: PLL)
  Today Pall FortéBio
  Group Danaher (Group)
Products Product laboratory equipment and instruments
  Product 2 investment banking
  Index term 2 Pall Corp–Danaher: investment, 201505–201508 acqu merger $13.8b net of cash/debt in cash $127.2/share
Person Person Gugino, Matthew E. (Danaher 201407 VP Investor Relations)
     


Danaher Corporation (NYSE: DHR) ("Danaher") announced today that its wholly-owned subsidiary, DH Europe Finance S.A. ("Danaher International"), has priced an offering of:

> €500 million principal amount of floating rate senior notes due 2017 at an offering price of 100.000% of the principal amount;

> €600 million principal amount of 1.000% senior notes due 2019 at an offering price of 99.696% of the principal amount;

> €800 million principal amount of 1.700% senior notes due 2022 at an offering price of 99.651% of the principal amount; and

> €800 million principal amount of 2.500% senior notes due 2025 at an offering price of 99.878% of the principal amount.


Danaher expects to receive net proceeds, after estimated expenses and the underwriters' discounts and commissions, of approximately €2.68 billion. Danaher anticipates using the net proceeds from the offering to pay a portion of the purchase price of the previously announced acquisition of Pall Corporation and for general corporate purposes. The senior notes will be fully and unconditionally guaranteed on a senior unsecured basis by Danaher. The offering is expected to close on July 8, 2015.

Deutsche Bank AG, London Branch, Merrill Lynch International, BNP Paribas, HSBC Securities (USA) Inc. and Morgan Stanley & Co. International plc are acting as joint book-running managers for the offering.

The offering is being made pursuant to an effective shelf registration statement on file with the U.S. Securities and Exchange Commission.

The offering of senior notes may be made only by means of a prospectus and prospectus supplement. A copy of the prospectus and prospectus supplement relating to the securities can be obtained from Deutsche Bank AG, London Branch at Winchester House, 1 Great Winchester Street, London EC2N 2DB, United Kingdom, Attention: GRS, Facsimile: +44 207 545 4455; and from Merrill Lynch International at 2 King Edward Street, London EC1A 1HQ, United Kingdom, Attention: Syndicate Desk, Facsimile +44 207 995 0048.

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, the senior notes or any other securities, nor shall there be any offer, solicitation or sale of any security mentioned in this press release in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.


ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world-class brands has leadership positions in some of the most demanding and attractive industries, including health care, environmental and industrial. The Company's globally diverse team of 71,000 associates is united by a common culture and operating system, the Danaher Business System.


FORWARD-LOOKING STATEMENTS

Statements in this release that are not strictly historical, including the statements regarding the offering of the senior notes, the anticipated use of proceeds and the anticipated acquisition of Pall Corporation, and any other statements regarding events or developments that we believe or anticipate will or may occur in the future, may be "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including Danaher's 2014 Annual Report on Form 10-K and Danaher's Quarterly Report on Form 10-Q for the first quarter of 2015. These forward-looking statements speak only as of the date of this release and Danaher and Danaher International do not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.


For further information: Matthew E. Gugino, Vice President, Investor Relations, Danaher Corporation, 2200 Pennsylvania Ave, NW, Suite 800W, Washington, D.C. 20037, Telephone: (202) 828-0850, Fax: (202) 828-0860

   
Record changed: 2016-01-10

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Danaher (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Partnering Opens 560x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Partnering Opens 560x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px